SEC Form S-1/A filed by CF Acquisition Corp. VIII (Amendment)
$CFFE
Business Services
Consumer Discretionary
Unavailable
Unavailable
Save time and jump to the most important pieces.
Actions by Exela Senior Management and Board Indicate a Disregard for Shareholder Value, Possible Corporate Governance Failures, and Possible Breaches of Fiduciary Duties to the Shareholders of the Company Shareholder Action is Required Immediately to Hold the Board and Company Management Accountable and Prevent Further Value Destruction Shareholder Representation on the Board and Corporate Governance Changes Are Needed Immediately BEVERLY HILLS, Calif., Nov. 7, 2022 /PRNewswire/ -- Today, X, LLC released the following open letter to shareholders of Exela Technologies, Inc. (NASDAQ:XELA, XELAP, CFFE)))
EFFECT - XBP Europe Holdings, Inc. (0001839530) (Filer)
424B3 - XBP Europe Holdings, Inc. (0001839530) (Filer)
S-1/A - XBP Europe Holdings, Inc. (0001839530) (Filer)
4 - XBP Europe Holdings, Inc. (0001839530) (Issuer)
3 - XBP Europe Holdings, Inc. (0001839530) (Issuer)
3 - XBP Europe Holdings, Inc. (0001839530) (Issuer)
LONDON and NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- XBP Europe, Inc. ("XBP Europe") announced today that it has completed its business combination with CF Acquisition Corp. VIII (NASDAQ:CFFE) ("CF VIII"). The combined company will operate as XBP Europe going forward and, beginning on November 30, 2023, XBP Europe shares will trade on the Nasdaq Stock Market under the ticker symbol "XBP" and its warrants will trade on the Nasdaq Stock Market under the ticker symbol "XBPEW". XBP Europe is a pan-European integrator of bills and payments. It connects buyers and suppliers, across industries, to optimize clients' bills and payments processes to advance digital transformation, improve market
Actions by Exela Senior Management and Board Indicate a Disregard for Shareholder Value, Possible Corporate Governance Failures, and Possible Breaches of Fiduciary Duties to the Shareholders of the Company Shareholder Action is Required Immediately to Hold the Board and Company Management Accountable and Prevent Further Value Destruction Shareholder Representation on the Board and Corporate Governance Changes Are Needed Immediately BEVERLY HILLS, Calif., Nov. 7, 2022 /PRNewswire/ -- Today, X, LLC released the following open letter to shareholders of Exela Technologies, Inc. (NASDAQ:XELA, XELAP, CFFE)))
Transaction values the European business at an enterprise value of $220 million Transaction is expected to close in the first half of 2023Exela Technologies, Inc. will indirectly own a majority of the new public company, named XBP Europe Holdings, Inc. IRVING, Texas and NEW YORK, Oct. 10, 2022 (GLOBE NEWSWIRE) -- XBP Europe, Inc. ("XBP Europe"), the European business of Exela Technologies Inc. (NASDAQ:XELA, XELAP))) ("Exela") and CF Acquisition Corp. VIII (NASDAQ:CFFE) ("CFFE"), a special purpose acquisition company sponsored by Cantor Fitzgerald, today announced that they have entered into a definitive merger agreement. After closing, the combined company will be called XBP Europe Holdin
SC 13G/A - XBP Europe Holdings, Inc. (0001839530) (Subject)
SC 13G/A - XBP Europe Holdings, Inc. (0001839530) (Subject)
SC 13G/A - XBP Europe Holdings, Inc. (0001839530) (Subject)
Gainers Blue Apron Holdings, Inc. (NASDAQ:APRN) climbed 133.5% to $12.82 after the company announced an agreement to be acquired by Wonder Group for $13 per share. OpGen, Inc. (NASDAQ:OPGN) shares jumped 109% to $0.4201 after the company requested to withdraw its registration statement on Form S-1. Novo Integrated Sciences, Inc. (NASDAQ:NVOS) shares gained 66.3% to $0.3343 after the company announced it signed a One Billion Dollar Master Collateral Transfer Agreement with Blacksheep Trust for the purpose and general use of monetization for a period of up to 15 years. CF Acquisition Corp. VIII (NASDAQ:CFFE) gained 61% to $29.51. Femasys Inc. (NASDAQ:FEMY) surged 48% to $2.2650 after HC
Gainers TransCode Therapeutics, Inc. (NASDAQ:RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138. FaZe Holdings Inc. (NASDAQ:FAZE) gained 46.9% to $0.2247 after falling over 4% on Friday. Avalo Therapeutics, Inc. (NASDAQ:AVTX) shares climbed 23.5% to $0.1472 after gaining 16% on Friday. The company recently announced the sale of its assets relating to AVTX-801 (D-galactose), AVTX-802 (D-mannose) and AVTX-803 (L-fucose) on Sept. 12. Biophytis S.A. (NASDAQ:BPTS) shares gained 22.3% to $1.1250 after the company and Skyepharma announced the signature of a partnership agreement for the production of regulatory ba
FaZe Holdings Inc. (NASDAQ:FAZE) shares rose 64.7% to $0.2520 in pre-market trading after falling over 4% on Friday. Biophytis S.A. (NASDAQ:BPTS) shares rose 31.5% to $1.21 in pre-market trading. Biophytis and Skyepharma sign a partnership agreement for the production of Sarconeos (BIO101). Avalo Therapeutics, Inc. (NASDAQ:AVTX) shares gained 24% to $0.1478 in pre-market trading after gaining 16% on Friday. The company recently announced the sale of its assets relating to AVTX-801 (D-galactose), AVTX-802 (D-mannose) and AVTX-803 (L-fucose) on Sept. 12. Knightscope, Inc.. (NASDAQ:KSCP) gained 17.7% to $0.8780 in pre-market trading. E-Home Household Service Holdings Limited (NASDAQ:EJH)